Fennec Pharmaceuticals Inc (FENC) Wheel Strategy

Running a FENC wheel strategy lets you generate consistent premium income on Fennec Pharmaceuticals Inc while setting your own entry and exit prices on the underlying. Fennec Pharmaceuticals Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own FENC, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best FENC wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on FENC, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable FENC wheel from a losing one.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the FENC wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your FENC wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.